News AstraZeneca PLC Nasdaq

Equities

AZN

US0463531089

Market Closed - Nasdaq Other stock markets 21:00:00 18/06/2024 BST			Pre-market 12:22:30
78.42 ^USD	-1.12%		78.6	+0.24%

11:58am	AstraZeneca's Truqap gets OK from EU for breast cancer form	AN
09:16am	AstraZeneca: EU approval in breast cancer	CF

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AstraZeneca's Truqap gets OK from EU for breast cancer form	10:58am	AN
AstraZeneca: EU approval in breast cancer	08:16am	CF
AstraZeneca Wins EU Approval for Breast Cancer Combination Treatment	07:34am	MT
Astrazeneca Says Truqap Plus Faslodex Approved In EU	07:01am	RE
Astrazeneca - Update on the CAPItello-290 Phase III trial for Truqap plus chemotherapy in advanced or metastatic triple-negative breast cancer	06-19	AQ
Squamous Cell Carcinoma Pipeline 2024 \| FDA Approvals, Clinical Trials, Therapies, MOA, ROA \| Hookipa Pharma, Zenith Epigenetics, HiFiBiO, Nanobiotix, GSK, AstraZeneca, VCN Biosciences, Moderna	06-19	AQ
AstraZeneca Signs Mobile Support Collaboration for Breast Cancer Patients	06-19	MT
Global markets live: Shell, UBS, Boeing, Berkshire Hathaway, Exxon...	06-18
AstraZeneca - IMFINZI plus chemotherapy approved in the US for mismatch repair deficient advanced or recurrent endometrial cancer	06-18	AQ
ASTRAZENECA : Goldman Sachs maintains a Buy rating	06-18	ZD
AstraZeneca plc Updates on the CAPItello-290 Phase III Trial for Truqap Plus Chemotherapy	06-18	CI
AstraZeneca disappointed by breast cancer drug trial results	06-18	AN
London follows US bullish trend	06-18
AstraZeneca: inconclusive trial in breast cancer	06-18	CF
AstraZeneca's Breast Cancer Combo Fails to Extend Overall Survival in Late-stage Trial	06-18	MT
UK Stocks-Factors to watch on June 18	06-18	RE
Ashtead profit declines; Whitbread sales rise	06-18	AN
AstraZeneca's breast cancer drug combination fails in late-stage trial	06-18	RE
AstraZeneca's Advanced Breast Cancer Drug Fails to Meet Primary Goals	06-18	DJ
AstraZeneca : Update on CAPItello-290 Phase III trial	06-18	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 05:02 pm